Q-1804

N/A

Report date: 2021/12/20 18:01:17

Base Information

Drug NameQ-1804
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionThymic stromal lymphopoietin inhibitors
TargetsThymic stromal lymphopoietin
Therapy Area/IndicationsAutoimmune DiseasesAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQure Biotechnology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQure Biotechnology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A